Prøve GULL - Gratis

What Sebi’s trading rules revamp means

Mint Chennai

|

January 13, 2026

The Securities and Exchange Board of India (Sebi) is proposing a major overhaul of trading rules, by simplifying longstanding regulations and shifting more day-to-day supervision to stock exchanges.

- Apoorva Ajith

What Sebi’s trading rules revamp means

In a consultation paper released on Friday, Sebi proposed merging existing trading norms into a single consolidated circular. This would be done by revising the Master Circular for Stock Exchanges and Clearing Corporations (MSECC) and the Master Circular for Commodity Derivatives (MCCD). The aim is to streamline compliance, remove outdated provisions, and update norms that are more than a decade old. Mint explains what Sebi is proposing and why it matters for stock exchanges.

The consultation paper outlines a broad set of operational and regulatory changes. Among the most significant is a proposal to raise the minimum net-worth requirement for brokers offering the margin trading facility (MTF) from ₹3 crore to ₹5 crore—or higher, if exchanges choose to prescribe stricter norms.

The existing threshold was first introduced in 2004 and was last reviewed in 2022.

Other proposals include:

Aligning timelines for submission of net-worth statements and auditor certificates

Removing market-making provisions no longer in use

Bringing liquidity enhancement schemes (LES) under a single, principle-based framework

FLERE HISTORIER FRA Mint Chennai

Mint Chennai

Mint Chennai

Lenskart wants artificial intelligence to test your eyes

It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

More companies to take a hit as labour codes debut

Reworked gratuity and leave encashments spell additional expenses for India Inc

time to read

2 mins

January 13, 2026

Mint Chennai

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Chennai

Trump’s investigation of Powell is also a warning to the next Fed chair

The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

States flag Almont-Kid syrup as tests find contaminants

Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol

time to read

1 mins

January 13, 2026

Mint Chennai

Mint Chennai

India at 100: Our choices today will define the next two decades

India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path

time to read

4 mins

January 13, 2026

Mint Chennai

Now, inheritance works without probate—but why it still matters

Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases

time to read

6 mins

January 13, 2026

Mint Chennai

Why VCs have a new deep-tech playbook

where fundraising starts to drag,\" said Chand.

time to read

1 min

January 13, 2026

Mint Chennai

TCS, HCLTech deliver Q3 revenue surprise

clearer.

time to read

2 mins

January 13, 2026

Mint Chennai

Mint Chennai

US productivity is rising and it risks warping monetary policy

America's neutral rate ought to be going up but will the Fed listen?

time to read

3 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size